X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pacap38 (40) 40
index medicus (32) 32
cyclase-activating polypeptide (21) 21
neurosciences (19) 19
animals (16) 16
humans (16) 16
male (14) 14
pituitary adenylate cyclase-activating polypeptide (14) 14
clinical neurology (13) 13
vip (13) 13
vasoactive-intestinal-peptide (12) 12
biochemistry & molecular biology (11) 11
female (11) 11
migraine (11) 11
headache (9) 9
neuropeptides (9) 9
pacap27 (9) 9
rat (9) 9
rats (9) 9
pituitary adenylate cyclase-activating polypeptide - pharmacology (8) 8
adult (7) 7
mice (7) 7
neurology (7) 7
pacap (7) 7
adenylate-cyclase (6) 6
expression (6) 6
messenger-rna (6) 6
pituitary adenylate cyclase-activating polypeptide - metabolism (6) 6
receptors (6) 6
research (6) 6
traumatic brain injury (6) 6
brain (5) 5
cell biology (5) 5
middle aged (5) 5
vasoactive intestinal polypeptide (5) 5
young adult (5) 5
biomedicine (4) 4
cross-over studies (4) 4
double-blind method (4) 4
genetic aspects (4) 4
medicine & public health (4) 4
middle meningeal artery (4) 4
neuropeptides - pharmacology (4) 4
pac (4) 4
pac1 protein (4) 4
pharmacology & pharmacy (4) 4
physiological aspects (4) 4
polypeptides (4) 4
receptor (4) 4
vasodilator agents - pharmacology (4) 4
arteries (3) 3
article (3) 3
brain injuries - metabolism (3) 3
brain ischemia - metabolism (3) 3
central-nervous-system (3) 3
cgrp (3) 3
double-blind (3) 3
drug therapy (3) 3
gene-related peptide (3) 3
health aspects (3) 3
healthy-volunteers (3) 3
heart rate - drug effects (3) 3
human provocation models (3) 3
immunohistochemical localization (3) 3
immunohistochemistry (3) 3
in-vitro (3) 3
internal medicine (3) 3
mast-cell degranulation (3) 3
mice, inbred c57bl (3) 3
multiple-myeloma (3) 3
nervous system (3) 3
nervous-system (3) 3
neurochemistry (3) 3
neurons (3) 3
neuropeptide (3) 3
pac1 (3) 3
pacap receptors (3) 3
pain medicine (3) 3
peptide (3) 3
peptides (3) 3
physiology (3) 3
pituitary adenylate cyclase-activating polypeptide - administration & dosage (3) 3
pituitary adenylate cyclase-activating polypeptide - adverse effects (3) 3
pituitary adenylate cyclase-activating polypeptide - genetics (3) 3
pituitary adenylate cyclase-activating polypeptide - therapeutic use (3) 3
primary headaches (3) 3
proteins (3) 3
proteomics (3) 3
radioimmunoassay (3) 3
rats, sprague-dawley (3) 3
review (3) 3
signal transduction - physiology (3) 3
vasoactive intestinal peptide - pharmacology (3) 3
vasodilation - drug effects (3) 3
adolescent (2) 2
aged (2) 2
alzheimers-disease (2) 2
analysis (2) 2
antihistamine (2) 2
attacks (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cephalalgia, ISSN 0333-1024, 4/2019, Volume 39, Issue 5, pp. 597 - 607
Objective To investigate the effect of the H1-antihistamine clemastine on the migraine-inducing abilities of pituitary adenylate cyclase activating peptide-38.... 
PACAP38 | migraine | PAC | receptor | antihistamine | mast cells
Journal Article
Peptides, 08/2019, pp. 170134 - 170134
Journal Article
Cephalalgia, ISSN 0333-1024, 7/2019, Volume 39, Issue 8, pp. 1049 - 1057
Objective To evaluate clinical criteria for headache associated with pituitary adenoma (HaPA) in the International Classification of Headache Disorders (ICHD)... 
Headache associated with pituitary adenoma | PACAP1-38 | CGRP | ICHD-3 | DIAGNOSIS | INTRASELLAR PRESSURE | CLINICAL CHARACTERISTICS | PACAP38 | MIGRAINE | NEUROSCIENCES | CLINICAL NEUROLOGY | PLAY | IMPROVEMENT | TRANSSPHENOIDAL SURGERY
Journal Article
Cephalalgia, ISSN 0333-1024, 4/2019, Volume 39, Issue 5, pp. 575 - 584
Objective To investigate the role of calcitonin gene-related peptide, pituitary adenylate cyclase-activating polypeptide-38 (PACAP38) and vasoactive intestinal... 
Headache | ATTACKS | INTESTINAL POLYPEPTIDE VIP | PACAP38 | RELEASE | MIGRAINE | NEUROSCIENCES | CLINICAL NEUROLOGY | PLASMA | PAIN | INCREASE | cluster headache | VIP | CGRP | EXPRESSION | CAPSAICIN
Journal Article
2006, Annals of the New York Academy of Sciences, ISBN 9781573315500, Volume 1070, xxi, 633
Book
STEM CELLS, ISSN 1066-5099, 04/2015, Volume 33, Issue 4, pp. 1153 - 1172
Journal Article
CEPHALALGIA, ISSN 0333-1024, 04/2019, Volume 39, Issue 5, pp. 597 - 607
Objective To investigate the effect of the H-1-antihistamine clemastine on the migraine-inducing abilities of pituitary adenylate cyclase activating... 
PAC receptor | MIDDLE MENINGEAL ARTERY | migraine | VASOACTIVE-INTESTINAL-PEPTIDE | RECEPTOR | PACAP38 | INFUSION | RELEASE | mast cells | NEUROSCIENCES | CLINICAL NEUROLOGY | ACTIVATING POLYPEPTIDE PACAP | MESSENGER-RNA | HEADACHE | HISTAMINE | antihistamine | MAST-CELL DEGRANULATION
Journal Article
Brain, ISSN 0006-8950, 1/2009, Volume 132, Issue 1, pp. 16 - 25
Journal Article
Journal Article
Peptides, ISSN 0196-9781, 06/2018, Volume 104, pp. 35 - 40
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 5/2015, Volume 112, Issue 21, pp. 6712 - 6717
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 03/2017, Volume 18, Issue 3, pp. 675 - 675
The neuropeptide pituitary adenylate cyclase activating polypeptide (PACAP) has two active forms, PACAP1-27 and PACAP1-38. Among the well-established actions... 
Neuroprotection | Carotid artery occlusion | Eye drops | PACAP | Ischemic retinopathy | eye drops | CYCLASE-ACTIVATING POLYPEPTIDE | BIOCHEMISTRY & MOLECULAR BIOLOGY | PACAP38 | LESION | CHEMISTRY, MULTIDISCIPLINARY | DELIVERY | RECOVERY | PATHWAY | neuroprotection | RETINOPATHY | ischemic retinopathy | INDUCED NEUROTOXICITY | RECEPTORS | EXPRESSION | carotid artery occlusion | Neuroprotective Agents - therapeutic use | Retina - metabolism | Rats, Wistar | Retinal Vessels - metabolism | Peptide Fragments - administration & dosage | Peptide Fragments - pharmacokinetics | Pituitary Adenylate Cyclase-Activating Polypeptide - pharmacokinetics | Rats | Retinal Vessels - pathology | Animals | Ischemia - drug therapy | Neuroprotective Agents - pharmacokinetics | Pituitary Adenylate Cyclase-Activating Polypeptide - therapeutic use | Ophthalmic Solutions | Mice | Peptide Fragments - therapeutic use | Pituitary Adenylate Cyclase-Activating Polypeptide - administration & dosage | Retinal Diseases - drug therapy | Neuroprotective Agents - administration & dosage | Occlusion | Diabetic retinopathy | Cornea | Polypeptides | Cytokines | Retina | Neuropeptides | Glial cells | Kinases | Eye | Pituitary adenylate cyclase-activating polypeptide | Brain research | Ischemia | Cerebral blood flow | Rodents | Diabetes | Topical application | Carotid artery | Index Medicus
Journal Article
Journal Article